Vaccine demonstrates protection against COVID-19 related hospitalization and death, and across different variants.
“These topline results with a single-shot COVID-19 vaccine candidate represent a promising moment,” said Paul Stoffels, MD, vice chairman of the executive committee and chief scientific officer at Johnson & Johnson, in a press release. “The potential to significan...
The Johnson & Johnson COVID-19 single-shot vaccine is compatible with standard vaccine storage and distribution channels enabling delivery to remote areas.4 The vaccine is estimated to remain stable for two years at -25 to -15°C, and a maximum of three months of which can ...
December 27, 2024 08:04 Trump urging TikTok ban halt, looks to focus on AI in second term December 31, 2024 10:26 This move by Speaker Johnson could help ‘build trust’ with Republicans, NY rep says December 27, 2024 03:27 Stock winners and losers: A year in review ...
DETROIT (FOX 2) - As the nation and the world move to vaccinate as many people as possible against COVID-19, the CDC and FDA announced Tuesday morning that the Johnson & Johnson vaccine distribution be paused to investigate a rare type of blood clotting. In a joint statement, the FDA ...
The United States has reached something of a turning point in its COVID-19 vaccination campaign, with ten states opening vaccine eligibility to all adults in coming days. This is what the Centers for Disease Control terms Phase 2 of vaccine elig...
(KTVU) - Nearly 4 million doses of the newest COVID-19 vaccine will start going into people's arms across the nation on Tuesday. The Johnson & Johnson vaccine only requires one injection, so the pharmaceutical giant is ramping up production as never before. "I really can&...
Johnson & Johnsonreports Q4 2024 and Full-Year 2024 results Johnson & Johnson(NYSE: JNJ) today announced results for third-quarter 2024. January 21, 2025 SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression ...
Norton Healthcare part of Phase 3 vaccine trial with the University of Kentucky and Baptist Health Lexington Author: Maggie Roetker Published: January 29, 2021 | Updated: August 15, 2024 The long-anticipated interim results of a Phase 3 clinical trial on Johnson & Johnson’s COVID-19 vacc...
U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic.